BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14560072)

  • 1. Individualized pharmacogenetic therapy: a critical analysis.
    Schmedders M; van Aken J; Feuerstein G; Kollek R
    Community Genet; 2003; 6(2):114-9. PubMed ID: 14560072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Targets in Advanced Therapeutics of Cancers: The Role of Pharmacogenetics.
    Abubakar MB; Gan SH
    Oncology; 2016; 91(1):3-12. PubMed ID: 27233906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential and limitations of personalized medicine in the doctor-patient relationship.
    Hapgood R
    Pharmacogenomics; 2003 Nov; 4(6):685-7. PubMed ID: 14596632
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacogenetic aspects of current pharmacotherapy].
    Slanar O; Zima T
    Cas Lek Cesk; 2010; 149(10):472-5. PubMed ID: 21121137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic considerations for late life depression therapy.
    Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics in future medical care -- implications for patients and physicians].
    Rogausch A; Brockmöller J; Himmel W
    Gesundheitswesen; 2005 Apr; 67(4):257-63. PubMed ID: 15856385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
    Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
    Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.
    Elie V; de Beaumais T; Fakhoury M; Jacqz-Aigrain E
    Pharmacogenomics; 2011 Jun; 12(6):827-43. PubMed ID: 21692614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and personalized medicine: the future for drug prescribing.
    Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
    J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the pharmacogenetics of asthma treatment.
    Weiss ST; Litonjua AA; Lange C; Lazarus R; Liggett SB; Bleecker ER; Tantisira KG
    Pharmacogenomics J; 2006; 6(5):311-26. PubMed ID: 16568148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based pharmacogenetics: Is it possible?
    Sychev DA; Malova EU
    Int J Risk Saf Med; 2015; 27 Suppl 1():S97-8. PubMed ID: 26639733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualization of drug therapy: history, present state, and opportunities for the future.
    Lesko LJ; Schmidt S
    Clin Pharmacol Ther; 2012 Oct; 92(4):458-66. PubMed ID: 22948891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine.
    Zineh I; Huang SM
    Biomark Med; 2011 Dec; 5(6):705-13. PubMed ID: 22103607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic considerations in the elderly patient.
    Bright DR; Calinski DM; Kisor DF
    Consult Pharm; 2015 Apr; 30(4):228-39. PubMed ID: 25893701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group-based and personalized care in an age of genomic and evidence-based medicine: a reappraisal.
    Maglo KN
    Perspect Biol Med; 2012; 55(1):137-54. PubMed ID: 22643722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of antipsychotic treatment in schizophrenia.
    Pouget JG; Müller DJ
    Methods Mol Biol; 2014; 1175():557-87. PubMed ID: 25150876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How personalized medicine is changing the rules of drug life exclusivity.
    Sullivan CG
    Pharmacogenomics; 2004 Jun; 5(4):429-32. PubMed ID: 15165178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of osteoporosis: towards novel theranostics for personalized medicine?
    Rojo Venegas K; Aguilera Gómez M; Cañada Garre M; Sánchez AG; Contreras-Ortega C; Calleja Hernández MA
    OMICS; 2012 Dec; 16(12):638-51. PubMed ID: 23215803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.